Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
최신 재무제표(Form-10K)에 따르면, Clearmind Medicine Inc의 총 자산은 $0이며, 순손실입니다.
CMND의 주요 재무 비율은 무엇인가요?
Clearmind Medicine Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Clearmind Medicine Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Clearmind Medicine Inc 주요 수익원은 Life Insurance and Pensions이며, 최신 수익 발표에서 수익은 37,811,000,000입니다. 지역별로는 Americas이 Clearmind Medicine Inc의 주요 시장이며, 수익은 14,582,000,000입니다.
Clearmind Medicine Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Clearmind Medicine Inc의 순손실은 $0입니다.